Manufacturing
Excellence in productivity and efficiency
At Arna Pharma, our world-class manufacturing capabilities and unwavering commitment to quality are the cornerstones of our success. We are dedicated to producing safe, effective, and reliable medications that enhance the lives of patients globally.
​
With globally accredited facility and advanced manufacturing technologies, Arna Pharma delivers both proprietary and contract manufacturing solutions across a wide range of dosage forms.
Sydney Facility
Our current state of the art manufacturing facility is located in Sydney, Australia has Global Regulatory Approvals & Certifications Our facility is audited and approved by leading regulatory authorities.​
​​​This state-of-the-art facility manufactures two of our flagship Dry Powder Inhalation products Bronchitol® indicated for Cystic Fibrosis and Aridol®/Osmohale®, a bronchial responsiveness test kit. It is equipped with unique, specialized equipment designed for high-precision pharmaceutical production
Key Equipment: •Niro PSD 5 Spray Drier •Planeta MG2 100 – High-speed encapsulation machine •Uhlmann B1240 Thermoformer Blister Packer •Serialization System: Mettler Toledo XMV TE with TS2660 Aggregation, integrated with Arvato CSDB Gateway •Water Treatment: Veolia VCD 500E 3 (USP 41 WFI, 750L/hr capacity) •Blending System: Mueller Column Lifter with 350L & 650L IBCs •Particle Milling: Frewitt Conwitt 150 Conical Mill
Our Site Approvals
Expanding Our Capabilities
To meet growing global demand and broaden our formulation expertise, Arna Pharma is expanding its manufacturing infrastructure. Our facility is being upgraded and commissioned with additional lines to support the production of:
​
-
Sterile Injectables
-
Oral Inhalation Products
-
Advanced Oral Solid and Liquid Formulations
This expansion underscores our commitment to technological advancement, product innovation, and the delivery of high-quality, regulatory-compliant medicines across a broader therapeutic spectrum.
